Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator

Neuroscience

Volumn 250, Issue , 2013, Pages 181-188

  Pfeilschifter, W ^a   Kashefiolasl, S ^a   Lauer, A ^a   Steinmetz, H ^a   Foerch, C ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Blood brain barrier; Intracerebral hemorrhage; Stroke; Thrombolysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; COLLAGENASE; EVANS BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; FUNCTIONAL OUTCOME; HEMATOMA VOLUME; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

BBB; BLOOD-BRAIN BARRIER; EB; EVANS BLUE; ICH; INTRACEREBRAL HEMORRHAGE; RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR; RT-PA; STROKE; THROMBOLYSIS; TISSUE PLASMINOGEN ACTIVATOR;

ANIMALS; CEREBRAL HEMORRHAGE; COLLAGENASES; DATA INTERPRETATION, STATISTICAL; EVANS BLUE; FIBRINOLYTIC AGENTS; FLUORESCENT DYES; HEMATOMA; MALE; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84883686690     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.003     Document Type: Article

References (22)

1. Arima H., Wang J.G., Huang Y., Heeley E., Skulina C., Parsons M.W., Peng B., Li Q., Su S., Tao Q.L., Li Y.C., Jiang J.D., Tai L.W., Zhang J.L., Xu E., Cheng Y., Morgenstern L.B., Chalmers J., Anderson C.S. Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology 2009, 73:1963-1968. INTERACT Investigators.
2. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
3. Czech B., Pfeilschifter W., Mazaheri-Omrani N., Strobel M.A., Kahles T., Neumann-Haefelin T., Rami A., Huwiler A., Pfeilschifter J. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem Biophys Res Commun 2009, 389:251-256.
4. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
5. Eissa A., Krass I., Bajorek B.V. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). J Clin Pharm Ther 2012, 37:620-629.
6. Foerch C., Arai K., Jin G., Park K.P., Pallast S., van Leyen K., Lo E.H. Experimental model of warfarin-associated intracerebral hemorrhage. Stroke 2008, 39:3397-3404.
7. Foerch C., Arai K., Van Cott E.M., van Leyen K., Lo E.H. Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. J Cereb Blood Flow Metab 2009, 29:1015-1021.
8. Foerch C., Rosidi N.L., Schlunk F., Lauer A., Cianchetti F.A., Mandeville E., Arai K., Yigitkanli K., Fan X., Wang X., van Leyen K., Steinmetz H., Schaffer C.B., Lo E.H. Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice. PLoS One 2013, 8(2):e54203.
9. Fry D.L., Mahley R.W., Weisgraber K.H., Oh S.Y. Simultaneous accumulation of Evans blue dye and albumin in the canine aortic wall. Am J Physiol 1977, 233:66-79.
10. Huynh T., Cox J.L., Massel D., Davies C., Hilbe J., Warnica W., Daly P.A. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project. Am Heart J 2004, 148:86-91. FASTRAK II Network.
11. Illanes S., Zhou W., Heiland S., Markus Z., Veltkamp R. Kinetics of hematoma expansion in murine warfarin-associated intracerebral hemorrhage. Brain Res 2010, 1320:135-142.
12. Kashefiolasl S., Foerch C., Pfeilschifter W. Graphite furnace atomic absorption spectrophotometry - a novel method to quantify blood volume in experimental models of intracerebral hemorrhage. J Neurosci Methods 2013, 213:147-150.
13. Kastrup A., Gröschel K., Ringer T.M., Redecker C., Cordesmeyer R., Witte O.W., Terborg C. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke 2008, 39:2385-2387.
14. Lees K.R., Bluhmki E., von Kummer R., Brott T.G., Toni D., Grotta J.C., Albers G.W., Kaste M., Marler J.R., Hamilton S.A., Tilley B.C., Davis S.M., Donnan G.A., Hacke W., Allen K., Mau J., Meier D., del Zoppo G., De Silva D.A., Butcher K.S., Parsons M.W., Barber P.A., Levi C., Bladin C., Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375:1695-1703. ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group.
15. Murray V., Norrving B., Sandercock P.A., Terént A., Wardlaw J.M., Wester P. The molecular basis of thrombolysis and its clinical application in stroke. J Intern Med 2010, 267:191-208.
16. Schellinger P.D., Fiebach J.B., Hoffmann K., Becker K., Orakcioglu B., Kollmar R., Jüttler E., Schramm P., Schwab S., Sartor K., Hacke W. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke 2003, 34:1674-1679.
17. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333(24):1581-1587.
18. Tanaka Y., Marumo T., Shibuta H., Omura T., Yoshida S. Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke. Brain Res Bull 2009, 78:158-163.
19. Tsuji K., Aoki T., Tejima E., Arai K., Lee S.R., Atochin D.N., Huang P.L., Wang X., Montaner J., Lo E.H. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005, 36:1954-1959.
20. Wang X., Tsuji K., Lee S.R., Ning M., Furie K.L., Buchan A.M., Lo E.H. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 2004, 35:2726-2730.
21. Zazulia A.R., Diringer M.N., Videen T.O., Adams R.E., Yundt K., Aiyagari V., Grubb R.L., Powers W.J. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001, 21:804-810.
22. Zinkstok S.M., Engelter S.T., Gensicke H., Lyrer P.A., Ringleb P.A., Artto V., Putaala J., Haapaniemi E., Tatlisumak T., Chen Y., Leys D., Sarikaya H., Michel P., Odier C., Berrouschot J., Arnold M., Heldner M.R., Zini A., Fioravanti V., Padjen V., Beslac-Bumbasirevic L., Pezzini A., Roos Y.B., Nederkoorn P.J. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke 2013, 44:1080-1084.